Loading...

Stock Performance

Change
Volume
Refresh quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

无需登录的加速器破解版

July 31, 2024 - Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results July 7, 2024 - Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA) July 2, 2024 - Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
加速网络连接

无需登录的加速器破解版

数据中心的网络连接:2021-6-13 · 了解数据中心的网络连接可如何帮助企业、云和电信运营商改善客户体验。 ... 通过降低延迟、提高吞吐量和增加可预测性，提供一流的客户体验。3 在网络功能虚拟化 (NFV) 环境中更一致地满足服务水平协议 (SLA) 要求。 在第二伕英特尔® 至强® 处理器上运行时，可众获得更佳的效果。

无需登录的加速器破解版

Investor Relations:
Argot Partners
Sam Martin / Maghan Meyers
(212) 600-1902
Email: sam@argotpartners.com / maghan@argotpartners.com

Media Relations:
Tracy Vineis
(617) 420-4839
Email: media@apellis.com

无需登录的加速器破解版

Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.

Sign Up
加速网络连接 Email Alerts RSS Feeds Contact IR